Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.
作者信息
Zachou Kalliopi, Dalekos George N
出版信息
Liver Int. 2011 Mar;31(3):277-9. doi: 10.1111/j.1478-3231.2011.02452.x. Epub 2011 Jan 25.
Abstract
摘要
相似文献
1
Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.
Liver Int. 2011 Mar;31(3):277-9. doi: 10.1111/j.1478-3231.2011.02452.x. Epub 2011 Jan 25.
2
Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection.
Liver Int. 2011 Mar;31(3):340-7. doi: 10.1111/j.1478-3231.2010.02417.x. Epub 2010 Dec 7.
3
Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.
Ann Hematol. 2011 Jan;90(1):111-2. doi: 10.1007/s00277-010-0962-9. Epub 2010 Apr 21.
4
Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.
Leukemia. 2005 Oct;19(10):1840-1. doi: 10.1038/sj.leu.2403914.
5
Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.
Liver Int. 2011 Mar;31(3):330-9. doi: 10.1111/j.1478-3231.2010.02332.x. Epub 2010 Aug 25.
6
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
Gastroenterol Hepatol. 2010 May;33(5):377-81. doi: 10.1016/j.gastrohep.2010.01.010. Epub 2010 Apr 2.
7
Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
Ann Rheum Dis. 2013 Feb;72(2):308-10. doi: 10.1136/annrheumdis-2012-202088. Epub 2012 Aug 28.
8
FDA: Increased HBV reactivation risk with ofatumumab or rituximab.
JAMA. 2013 Oct 23;310(16):1664. doi: 10.1001/jama.2013.281115.
9
Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge.
Leuk Lymphoma. 2010 Sep;51(9):1592-5. doi: 10.3109/10428194.2010.509456.
10
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.
Hepatology. 2006 Feb;43(2):209-20. doi: 10.1002/hep.21051.
引用本文的文献
1
Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat.
World J Hepatol. 2013 Jul 27;5(7):387-92. doi: 10.4254/wjh.v5.i7.387.
2
Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
J Clin Virol. 2013 Jun;57(2):115-9. doi: 10.1016/j.jcv.2013.01.016. Epub 2013 Feb 17.
Zotero 插件